Persistent infection with high-risk human papilloma viruses: cohort study, Mérida, Venezuela.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4631573)

Published in Ecancermedicalscience on October 08, 2015

Authors

Luis Téllez1, Elvia Michelli2, José Andrés Mendoza1, Silvana Vielma1, María-Eugenia Noguera3, Diana Callejas4, María Cavazza5, María Correnti6

Author Affiliations

1: Los Andes University, Department of Microbiology, Mérida CP 5101, Venezuela.
2: Los Andes University, Department of Microbiology, Mérida CP 5101, Venezuela ; University of Orient, Department of Bioanalysis, Sucre CP 6101, Venezuela.
3: Los Andes University, Department of Gynecology and Obstetrics, Mérida CP 5101, Venezuela.
4: University of Zulia (LUZ), Regional Reference Virology Laboratory, Maracaibo CP 4011, Zulia.
5: Institute of Biomedicine, MPPS, Caracas CP 10104, Venezuela.
6: Institute of Oncology and Haematology, MPPS, Caracas CP 1050, Venezuela.

Articles cited by this

Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature (1986) 17.77

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med (2007) 9.53

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet (2005) 7.09

Papillomaviruses in the causation of human cancers - a brief historical account. Virology (2009) 5.46

Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis (2010) 4.42

Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev (2004) 3.52

Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr (2003) 2.94

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol (2008) 2.91

Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis (2004) 2.77

Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis (2005) 2.51

The known unknowns of HPV natural history. J Clin Invest (2011) 2.39

Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol (2004) 2.34

Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol (2008) 1.88

Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev (2010) 1.85

Chapter 12: Prophylactic HPV vaccines: underlying mechanisms. Vaccine (2006) 1.73

Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol (1998) 1.53

Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics (2009) 1.48

Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer (2009) 1.37

Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev (2006) 1.34

Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics (2009) 1.18

International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol (2003) 1.13

Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study. Infect Agent Cancer (2013) 0.93

Human papillomavirus persistence in young unscreened women, a prospective cohort study. PLoS One (2011) 0.92

Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial. BMC Infect Dis (2013) 0.90

Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women. Infect Agent Cancer (2007) 0.88

Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain. BMC Infect Dis (2009) 0.87

Modulation of apoptotic pathways by human papillomaviruses (HPV): mechanisms and implications for therapy. Viruses (2012) 0.87

The clinical utility of HPV DNA testing in cervical cancer screening strategies. Indian J Med Res (2009) 0.86

Ethical principles for the guidance of physicians in medical research--the Declaration of Helsinki. Bull World Health Organ (2001) 0.83

Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area. Invest Clin (2009) 0.78

HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia. Obstet Gynecol Int (2013) 0.78

Correlation of human papilloma virus infection with cytology, colposcopy and histopathological examination of the bioptic tissue in low- and high-grade intraepithelial lesions. Eur J Gynaecol Oncol (2012) 0.77

Prevalence of human papillomavirus types 16, 18, and 45 in women with cervical intraepithelial changes: associations with colposcopic and histological findings. Medicina (Kaunas) (2012) 0.77

Presence of human papillomavirus infection determined by hybrid capture assay in cervical lesions in a Venezuelan population. Invest Clin (2010) 0.77

Human papillomavirus types distribution in eastern Sicilian females with cervical lesions. A correlation with colposcopic and histological findings. Pathol Oncol Res (2013) 0.77